Sponsors (4)
The bill channels targeted, short-term federal funding and training to expand and rigorously evaluate treatments for veterans with chronic mTBI—improving care and evidence—but does so with limited-duration funding, modest federal cost, and risks of disrupting longer-term research or diverting existing VA mental-health resources.
Veterans with chronic mild traumatic brain injury (mTBI) would gain access to new, rigorously tested neurorehabilitation treatments through funded clinical trials and programs, while VA clinicians and staff receive training and outreach to improve awareness and access to those treatments.
Veterans and other mental-health patients would benefit from dedicated funding ($30 million authorized across FY2026–FY2028) to develop and test mTBI interventions that could reduce suicidality and related risk factors.
Research and treatment quality would improve because the program prioritizes experienced research/treatment providers, requires rigorous evaluation, and mandates annual reporting—producing better evidence to guide VA treatment decisions.
Veterans and research institutions face disruption risk because the program’s three-year authorization may be too short for continuity of promising clinical trials and long-term follow-up studies.
Taxpayers would fund the program’s authorized $30 million over three years, adding to federal spending obligations.
Veterans and other VA mental-health patients could see resources diverted if the program uses amounts from general mental health care without additional appropriations, reducing funding available for other services.
Based on analysis of 2 sections of legislative text.
Creates a VA grant program to fund randomized trials and neurorehabilitation for chronic mild TBI in veterans, authorizes $30M (FY2026–28), grants up to $5M, and sunsets after 3 years.
Introduced November 6, 2025 by David Harold McCormick · Last progress November 6, 2025
Creates a VA TBI Innovation Grant Program to fund development, implementation, and evaluation of randomized clinical-trial approaches and neurorehabilitation treatments for veterans with chronic mild traumatic brain injury (mTBI). The program is authorized $30 million for FY2026–FY2028, may award grants up to $5 million per recipient per year, must issue regulations within 180 days, requires reporting and evaluations, and sunsets three years after enactment. The Secretary must prioritize experienced applicants, align the program with an existing VA suicide-prevention grant program, permit use of available mental health care funds, and provide regular reports to Congress on program activities and results.